BeOne Medicines (BEIGF) Other financing activities (2016 - 2026)
BeOne Medicines (BEIGF) reported Other financing activities of -$3.2 million for Q1 2026, down 8.3% quarter-over-quarter from -$3.0 million in Q4 2024.
BeOne Medicines (BEIGF) Other financing activities (2016 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 6 years of Other financing activities data on file, last reported at -$3.2 million in Q1 2026.
- Other financing activities for Q1 2026 came in at -$3.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.2 million (down 8.3% YoY), and the FY2019 annual result was $4.0 million, changed N/A from the prior year.
- Other financing activities retreated to -$3.2 million in Q1 2026 per BEIGF's latest filing, from -$3.0 million in the prior quarter.
- Over five years, Other financing activities peaked at -$3.0 million in Q4 2024 and troughed at -$3.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.25 Mn |
| Mar 31, 2026 | -3.25 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Dec 31, 2018 | -414,000.00 |
| Dec 31, 2018 | -414,000.00 |
| Sep 30, 2018 | 414,000.00 |
| Sep 30, 2018 | 414,000.00 |
| Jun 30, 2018 | -414,000.00 |
| Jun 30, 2018 | -414,000.00 |
| Mar 31, 2018 | 414,000.00 |
| Mar 31, 2018 | 414,000.00 |
| Dec 31, 2017 | -13.85 Mn |
| Dec 31, 2017 | -13.85 Mn |
| Dec 31, 2016 | 740,000.00 |
| Dec 31, 2016 | 740,000.00 |
| Mar 31, 2016 | 1.48 Mn |
| Mar 31, 2016 | 1.48 Mn |